Isothermal kinase-triggered supramolecular assemblies as drug sensitizers† † Electronic supplementary information (ESI) available: General materials and methods, chemical synthesis and procedures and supplementary results. See DOI: 10.1039/c9sc04317a
Ontology highlight
ABSTRACT: Protein kinases, the main regulators of a vast map of cellular processes, are the most attractive targets in drug discovery. Despite a few successful examples of protein kinase inhibitors, the drug discovery strategy of downregulating protein kinase activity has been quite limited and often fails even in animal models. Here, we utilize protein kinase A (PKA) activity to design PKA-triggered supramolecular assemblies with anticancer activities. Grafting a suitable peptide to PNIPAM raises the critical temperature of the LCST polymer above body temperature. Interestingly, the corresponding phosphorylated polymer has a critical temperature below body temperature, making this peptide-appended PNIPAM a suitable polymer for the PKA-triggered supramolecular assembly process. PKA-triggered assembly occurs selectively in PKA-upregulated MCF-7 cells, which disturbs the cytoskeleton and sensitizes cancer cells against doxorubicin. The chemosensitization is also observed in vivo to identify effective tumor inhibitors with satisfactory biocompatibility. Overall, this phosphorylation-induced (in principle, PKA-catalyzed) supramolecular assembly opens up a promising chemotherapy strategy for combating kinase-upregulated cancer. A nonapeptide grafted LCST polymer undergoes enzymatic phosphorylation to assemble, which selectively disrupts PKA overexpressing cancer cells via kinetics targeting.
SUBMITTER: Liu D
PROVIDER: S-EPMC8145944 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA